SECSONAR

$ANIK

Anika Therapeutics, Inc.

NASDAQ

Up 21% since last report

47% below 52-week high

FCF positive

Insider cost basis

Insiders bought — stock holding above

+3.0%vs buy

Insider buy $14.66Now $15.10

Find before everyone else

SEC filings, insider trades & earnings for ANIK — in one place.